Regional Anesthesia for Back Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how regional anesthesia can reduce the need for opioids after back surgery. Researchers are testing whether injecting a mix of bupivacaine (a numbing medication) and clonidine (which can enhance pain relief) before surgery lowers post-operative pain compared to a placebo. The trial aims to help people recovering from common lumbar spine surgeries avoid long-term opioid use. Individuals undergoing specified types of spine surgery who are not currently using opioids might be suitable candidates for this trial. As a Phase 4 trial, the research focuses on understanding how this already FDA-approved and effective treatment can benefit more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are opioid tolerant, meaning you take more than 30mg of morphine equivalents daily.
What is the safety track record for Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine and Normal Saline?
Research has shown that bupivacaine with epinephrine, when combined with clonidine, is generally well-tolerated. Bupivacaine often numbs specific areas during surgery or dental work by blocking nerve signals. Epinephrine extends the numbing effect and reduces bleeding, while clonidine can enhance pain relief.
Although these medications are usually safe, some rare risks exist. For instance, reports have indicated serious heart problems when bupivacaine is used in certain situations like childbirth, though these cases are uncommon.
Most people tolerate this combination well, but discussing any concerns with a healthcare provider before joining a clinical trial is important. They can help clarify the benefits and risks for individual health.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about using bupivacaine combined with clonidine for back surgery because it offers a potentially more effective pain management approach than standard options like general anesthesia or basic local anesthetics. This treatment is unique because it uses a regional anesthesia technique known as the erector spinae plane block (ESPB), which precisely targets the lumbar area to provide pain relief. The addition of clonidine, a medication that enhances the effects of bupivacaine, might extend pain relief duration, making it possible to reduce the need for opioids after surgery. This targeted approach could lead to quicker recovery times and fewer side effects compared to traditional methods.
What evidence suggests that this trial's treatments could be effective in reducing post-operative opioid requirements for back surgery?
In this trial, participants will receive either a placebo or an investigational treatment. Research has shown that a mix of bupivacaine and epinephrine for local anesthesia effectively numbs areas for surgery, providing significant pain relief. This combination reduces pain during and after procedures. Participants in the investigational arm will receive bupivacaine with epinephrine and clonidine, which extends the anesthetic effect and may reduce the need for opioid painkillers after surgery. Together, these components aim to keep patients comfortable with less reliance on opioids after back surgery. This approach could be a promising way to manage pain and lower the risk of opioid overuse.23678
Who Is on the Research Team?
John O'Toole, M.D., M.S.
Principal Investigator
Rush University Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 undergoing specific lumbar spinal surgeries, who can consent to participate. It's not for those with advanced kidney or liver disease, opioid tolerance, pregnancy, ongoing worker's comp cases, allergies to local anesthetics like bupivacaine or clonidine, other surgical indications besides degenerative disease, pain devices in place, or conditions affecting pain evaluation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative
Patients receive either a placebo or ESPB with bupivacaine plus clonidine immediately prior to surgery
Treatment
Participants undergo minimally invasive lumbar spine surgery with perioperative pain management
Follow-up
Participants are monitored for safety and effectiveness after treatment, including opioid consumption and complications
What Are the Treatments Tested in This Trial?
Interventions
- Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine
- Normal Saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
John O'Toole
Lead Sponsor